<DOC>
	<DOCNO>NCT01285076</DOCNO>
	<brief_summary>This multi-center , observational , retrospective cross-sectional study conduct cohort consecutively select participant Type 2 diabetes mellitus ( DM ) treat sulphonylurea ( SU ) monotherapy SU + metformin ( MF ) combination therapy cardiologist , nephrologist , neurologist , family practice doctor least 6 month prior Study Enrollment .</brief_summary>
	<brief_title>Evaluation Low Blood Sugar Events Participants With Diabetes ( MK-0431-401 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Participants diagnose Type 2 DM . Participants least 30 year age time Type 2 DM diagnosis . Participants treat SU monotherapy SU + MF combination therapy least 6 month prior enrollment . Participants receive diabetes care cardiologist , nephrologist , neurologist , family practice doctor least 6 month . Participants clinical record health care center . Participants whose medical record minimum core data set find ; core data define : age , gender , duration diabetes/age diagnosis , glucoselowering medication ( brand generic name , dosage , dose frequency , start stop date ) since start antihyperglycemic medication . Participants Type 1 DM . Participants pregnant gestational DM . Participants receive antidiabetic treatment endocrinologist/diabetologist previous 6 month . Participants require daily concomitant usage insulin . Participants receive oral diabetes medication SU SU + MF . Participants already participate clinical trial clinical study . Participants would impossible complete questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>